Citation Impact
Citing Papers
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome
2015 StandoutNobel
Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis☆☆☆★★★
1998
Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen
1999
The impact of allergic rhinitis on bronchial asthma
1998
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Overview of comorbid associations of allergic rhinitis
1997
Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma
1995
Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition
2000
One Airway, One Disease
1997
The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis
2005
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003
2004 Standout
The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials
2008 Standout
Cardiovascular Safety of FexofenadineHCl
1999
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Rhinosinusitis and Asthma
1999
The influence of cisapride and clarithromycin on QT intervals in healthy volunteers
1998
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Clinical practice guideline on diagnosis and treatment of hyponatraemia
2014 Standout
Cytokine and Other Immunologic Markers in Chronic Fatigue Syndrome and Their Relation to Neuropsychological Factors
2001
A definitive or thorough phase 1 QT ECG trial as a requirement for drug safety assessment
2004
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers
2016
Adenosine receptors as drug targets — what are the challenges?
2013
Drug‐induced prolongation of the QT interval: regulatory dilemmas and implications for approval and labelling of a new chemical entity
2002
Herb-Drug Interactions
2005 Standout
Adenosine
2014
Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures
2009 Standout
Continuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergy
1999
Drug-Induced Prolongation of the QT Interval
2004
Cardiovascular Safety of Salmeterol in COPDa
2003
QT interval monitoring during clinical studies with mizolastine, a new H1 antihistamine
1999
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
2011 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology
2000
Opioid Complications and Side Effects
2008 Standout
Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval
2006
Update: Clinically Significant Cytochrome P‐450 Drug Interactions
1998
Part 14: Pediatric Advanced Life Support
2010 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Study of cardiac repolarization in healthy volunteers performed with mizolastine, a new H1‐receptor antagonist
1999
Works of Bruce E. McNutt being referenced
A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease
2012
A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease
2012
Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variability
1996
Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: Rationale and design of a prospective, randomized, multicenter study
2010
Pharmacokinetics of Terfenadine in Healthy Elderly Subjects
1992
Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome
1996
Efficacy and safety of 30-minute infusions of conivaptan in euvolemic and hypervolemic hyponatremia
2011
Safety and efficacy of terfenadine/pseudoephedrine versus clemastine/phenylpropanolamine in the treatment of seasonal allergic rhinitis.
1993
Effect of terfenadine in asthmatic patients.
1992